Inventor
SCADDEN DAVID T
US36 patents
⚠️ This page may combine multiple inventors who share the name “SCADDEN DAVID T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GEN HOSPITAL CORP
10 patentsUS6448054B1Sep 10, 2002
Purposeful movement of human migratory cells away from an agent source
GEN HOSPITAL CORP103 citations95
US7141363B2Nov 28, 2006
Purposeful movement of human migratory cells away from an agent source
GEN HOSPITAL CORP20 citations92
US7775469B2Aug 17, 2010
Purposeful movement of human migratory cells away from an agent source
GEN HOSPITAL CORP9 citations83
US7635477B2Dec 22, 2009
Parathyroid hormone receptor activation and stem and progenitor cell expansion
GEN HOSPITAL CORP6 citations70
US7462483B2Dec 9, 2008
p27 and p21 in gene therapies
GEN HOSPITAL CORP3 citations63
US7943136B2May 17, 2011
Parathyroid hormone receptor activation and stem and progenitor cell expansion
GEN HOSPITAL CORP3 citations60
US7429383B2Sep 30, 2008
Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
GEN HOSPITAL CORP3 citations59
US8802104B2Aug 12, 2014
Parathyroid hormone receptor activation and stem and progenitor cell expansion
GEN HOSPITAL CORP0 citations50
US7776334B2Aug 17, 2010
Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
GEN HOSPITAL CORP0 citations50
US7951364B2May 31, 2011
CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
GEN HOSPITAL CORP0 citations49
HARVARD COLLEGE
8 patentsUS5677139AOct 14, 1997
In vitro differentiation of CD34+ progenitor cells into T lymphocytes
HARVARD COLLEGE59 citations94
US10570207B2Feb 25, 2020
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE5 citations82
US10280225B2May 7, 2019
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE10 citations82
US12152080B2Nov 26, 2024
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE0 citations61
US10906980B2Feb 2, 2021
Compositions and methods for non-myeloablative conditioning
HARVARD COLLEGE0 citations61
US12514865B2Jan 6, 2026
Biomaterial-based antigen free vaccine and the use thereof
HARVARD COLLEGE0 citations56
US11752238B2Sep 12, 2023
Recapitulating the hematopoietic niche to reconstitute immunity
HARVARD COLLEGE1 citations55
US11116819B2Sep 14, 2021
Methods and compositions for mobilizing stem cells
HARVARD COLLEGE0 citations41
GENENTECH INC
4 patentsUS5709858AJan 20, 1998
Antibodies specific for Rse receptor protein tyrosine kinase
GENENTECH INC30 citations96
US6096527AAug 1, 2000
Nucleic acids encoding protein tryosine kinases
GENENTECH INC10 citations82
US6001621ADec 14, 1999
Protein tyrosine kinases
GENENTECH INC10 citations74
US6087144AJul 11, 2000
Protein tyrosine kinases
GENENTECH INC7 citations73
MASSACHUSETTS GEN HOSPITAL
4 patentsUS12193996B2Jan 14, 2025
Monocyte compositions and methods for the treatment of infectious disease
MASSACHUSETTS GEN HOSPITAL0 citations53
US10961308B2Mar 30, 2021
Embigin inhibition for promotion of hematopoietic stem and progenitor cell expansion
MASSACHUSETTS GEN HOSPITAL0 citations51
US11564942B2Jan 31, 2023
Methods for generating universal and custom MHC/HLA-compatible hematopoietic progenitor cells
MASSACHUSETTS GEN HOSPITAL0 citations46
US9750767B2Sep 5, 2017
IL-18 inhibition for promotion of early hematopoietic progenitor expansion
MASSACHUSETTS GEN HOSPITAL0 citations41